Effectiveness of Using Interactive Consulting System to Enhance Informed Choice

October 25, 2023 updated by: Yingfeng Zheng, Sun Yat-sen University

Effectiveness of Using Interactive Consulting System Based on Large Language Model to Enhance Informed Choice of Cataract Patients: a Non-inferiority Randomized Controlled Trial

To compare the performance of an interactive chatbot versus senior ophthalmologists for enhancing informed decisions made by cataract patients. The chatbot was built based on large language models, and could generate medical expert-level responses.

Study Overview

Detailed Description

Cataract surgery is the only way to treat age-related cataract. For patients at early or moderate stages, cataract surgery is an elective surgery without objective indications. Therefore the patients are uaually not aware whether they should receive the surgery. The number of trained and qualified ophthalmologists are limited in China and lots of patients cannot have detailed consultation with ophthalmologists. As a result, many patients still have doubts about whether they should receive cataract surgery or not. In this study, we aim to assess the effectiveness of an interactive chatbot based on large language models versus senior ophthalmologists to enhance informed decisions made by cataract patients.

Study Type

Interventional

Enrollment (Estimated)

660

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510000
        • Recruiting
        • Zhognshan Ophthalmic Center, Sun Yat-sen University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

46 years to 76 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Individuals aged 45-80 years who have been resident in the selected study district for more than six months;
  2. A definite diagnosis of age-related cataract;
  3. Having not received cataract surgery;
  4. Willing to participate the study and provide informed consent.

Exclusion Criteria:

  1. Bilateral blindness (presenting distance visual acuity worse than 3/60);
  2. Having ocular, hearing or mental disorders precluding reading or telephone interview;
  3. Ocular disorders other than cataract leading to permanent vision loss that could not be corrected through cataract surgery;
  4. Having cataract surgery contraindication.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Interactive chatbot
A chatbot embedded into a mobile application which is able to bidirectionally interact with patients and provide standard general information, quantitative risk information on the possible outcomes of cataract surgery.
A chatbot embedded into a mobile application which is able to bidirectionally interact with patients and provide standard general information, quantitative risk information on the possible outcomes of cataract surgery.
Active Comparator: Senior ophthalmologists
Senior ophthalmologists would communicate with patients and provide standard general information, quantitative risk information on the possible outcomes of cataract surgery.
Senior ophthalmologists would communicate with patients and provide standard general information, quantitative risk information on the possible outcomes of cataract surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Informed choice about cataract surgery (the proportion of participants who make an informed choice,which is defined as a good knowledge score and an intention that is consistent with their attitude score)
Time Frame: 2 weeks post intervention
Informed choice is an aggregated measure of multiple measurements, including knowledge (a 12-item questionnaire that assesses conceptual (items 1-10) and numerical (items 11-12) knowledge), attitudes (6 items, with 5 responses for each), and intentions (single item with 5 responses)
2 weeks post intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accuracy of speech recognition by the Interactive Consulting System
Time Frame: Immediately after speech data sent to the server and processed
The researchers will manually check the content of patients' speech and that generated after speech recognition by the mobile application
Immediately after speech data sent to the server and processed
Utilization and acceptability of the Interactive Consulting System (1)
Time Frame: two weeks post intervention
The proportion of participants who could read the information all the way through
two weeks post intervention
Utilization and acceptability of the Interactive Consulting System (2)
Time Frame: two weeks post intervention
The proportion of participants who agree that the information is new
two weeks post intervention
Utilization and acceptability of the Interactive Consulting System (3)
Time Frame: two weeks post intervention
The proportion of participants who agree that the length is just about right
two weeks post intervention
Utilization and acceptability of the Interactive Consulting System (4)
Time Frame: two weeks post intervention
The proportion of participants who think the information is balanced
two weeks post intervention
Utilization and acceptability of the Interactive Consulting System (5)
Time Frame: two weeks post intervention
The proportion of participants who agree that the Interactive Consulting System is clear and easy to understand
two weeks post intervention
Utilization and acceptability of the Interactive Consulting System (6)
Time Frame: two weeks post intervention
The proportion of participants who find the information helpful
two weeks post intervention
Utilization and acceptability of the Interactive Consulting System (7)
Time Frame: two weeks post intervention
The proportion of participants who feel it worth recommending to others
two weeks post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yingfeng Zheng, MD, PhD, Zhongshan Ophthalmic Center, Sun Yat-sen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2023

Primary Completion (Estimated)

December 1, 2023

Study Completion (Estimated)

December 31, 2023

Study Registration Dates

First Submitted

January 23, 2020

First Submitted That Met QC Criteria

January 27, 2020

First Posted (Actual)

January 29, 2020

Study Record Updates

Last Update Posted (Actual)

October 26, 2023

Last Update Submitted That Met QC Criteria

October 25, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2020KYPJ003

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Deidentified will be shared after the study being published.

IPD Sharing Time Frame

The data will be available upon request after the study being accepted by peer-reviewed journal and published online.

IPD Sharing Access Criteria

The data will be available upon request. Requestors will be asked to sign data sharing agreements.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Age-related Cataract

Clinical Trials on An interactive chatbot for patient decision aid

Subscribe